Bank of New York Mellon’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-46,532
Closed -$68K 4637
2022
Q2
$68K Sell
46,532
-378,244
-89% -$553K ﹤0.01% 4299
2022
Q1
$489K Buy
424,776
+104,599
+33% +$120K ﹤0.01% 3723
2021
Q4
$800K Buy
320,177
+16,414
+5% +$41K ﹤0.01% 3513
2021
Q3
$1.56M Buy
303,763
+28,006
+10% +$143K ﹤0.01% 3141
2021
Q2
$2.29M Sell
275,757
-69,655
-20% -$579K ﹤0.01% 2896
2021
Q1
$3.01M Sell
345,412
-5,535
-2% -$48.2K ﹤0.01% 2680
2020
Q4
$3.81M Buy
350,947
+436
+0.1% +$4.74K ﹤0.01% 2490
2020
Q3
$4.18M Sell
350,511
-6,464
-2% -$77.1K ﹤0.01% 2310
2020
Q2
$5.73M Buy
356,975
+3,294
+0.9% +$52.9K ﹤0.01% 2144
2020
Q1
$5.49M Sell
353,681
-15,471
-4% -$240K ﹤0.01% 2032
2019
Q4
$9.08M Buy
369,152
+46,633
+14% +$1.15M ﹤0.01% 2031
2019
Q3
$3.33M Buy
322,519
+5,657
+2% +$58.4K ﹤0.01% 2475
2019
Q2
$3.98M Buy
316,862
+45,110
+17% +$566K ﹤0.01% 2446
2019
Q1
$3.37M Buy
271,752
+13,310
+5% +$165K ﹤0.01% 2517
2018
Q4
$1.59M Buy
258,442
+33,020
+15% +$203K ﹤0.01% 2844
2018
Q3
$2.39M Sell
225,422
-342
-0.2% -$3.62K ﹤0.01% 2744
2018
Q2
$3.06M Buy
225,764
+6,012
+3% +$81.4K ﹤0.01% 2631
2018
Q1
$3.9M Buy
219,752
+6,769
+3% +$120K ﹤0.01% 2477
2017
Q4
$2.67M Buy
212,983
+10,805
+5% +$136K ﹤0.01% 2667
2017
Q3
$3.85M Buy
202,178
+5,140
+3% +$97.9K ﹤0.01% 2468
2017
Q2
$2.98M Buy
197,038
+201
+0.1% +$3.04K ﹤0.01% 2602
2017
Q1
$3.38M Buy
196,837
+14,978
+8% +$257K ﹤0.01% 2539
2016
Q4
$2.2M Buy
181,859
+16,040
+10% +$194K ﹤0.01% 2789
2016
Q3
$1.63M Sell
165,819
-3,533
-2% -$34.8K ﹤0.01% 2892
2016
Q2
$1.74M Buy
169,352
+2,866
+2% +$29.4K ﹤0.01% 2798
2016
Q1
$2.02M Buy
166,486
+47,951
+40% +$581K ﹤0.01% 2652
2015
Q4
$1.9M Sell
118,535
-4,378
-4% -$70.1K ﹤0.01% 2739
2015
Q3
$1.58M Sell
122,913
-14,842
-11% -$191K ﹤0.01% 2875
2015
Q2
$3.31M Buy
137,755
+60,355
+78% +$1.45M ﹤0.01% 2604
2015
Q1
$1.45M Buy
77,400
+20,734
+37% +$389K ﹤0.01% 3081
2014
Q4
$1.07M Sell
56,666
-3,561
-6% -$67.2K ﹤0.01% 3265
2014
Q3
$1.63M Buy
60,227
+9,122
+18% +$247K ﹤0.01% 3017
2014
Q2
$1.59M Buy
51,105
+24,355
+91% +$758K ﹤0.01% 3038
2014
Q1
$609K Buy
26,750
+525
+2% +$12K ﹤0.01% 3505
2013
Q4
$545K Buy
26,225
+2,664
+11% +$55.4K ﹤0.01% 3541
2013
Q3
$942K Buy
23,561
+30
+0.1% +$1.2K ﹤0.01% 3270
2013
Q2
$662K Buy
+23,531
New +$662K ﹤0.01% 3384